Form 4: Kathleen Sebelius Reports Stock Option Grant and Exercise in Humacyte, Inc. (HUMA)
SEC Form 4 Filing
Director Kathleen Sebelius reports the acquisition of stock options and the exercise of previously held options in Humacyte, Inc.
Summary
- Kathleen Sebelius, a director of Humacyte, Inc. (HUMA), reported changes in her beneficial ownership of the company's securities.
- On June 13, 2024, she acquired 50,000 stock options with an exercise price of $7.20, exercisable in installments starting June 13, 2025, and expiring on June 13, 2034.
- On June 14, 2024, she exercised 39,389 stock options with an exercise price of $2.56, acquiring 39,389 shares of common stock.
Sentiment
Score: 6
Explanation: The sentiment is neutral. The filing simply reports transactions. The acquisition of options could be seen as slightly positive, but it's a routine disclosure.
Positives
- The acquisition of new stock options could indicate a positive outlook by the director regarding the company's future performance.
Future Outlook
The director's actions suggest a continued involvement and stake in the company's future.
Industry Context
Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. These filings are closely watched by investors for signals about management's confidence in the company's prospects.
Stakeholder Impact
- The filing provides transparency to shareholders regarding insider transactions.
Key Dates
| Date | Description |
|---|---|
| 09/01/2018 | Original date of stock options that were exercised. |
| 06/13/2024 | Date of stock option grant (50,000 options at $7.20) and transaction date. |
| 06/14/2024 | Date of stock option exercise (39,389 options at $2.56). |
| 06/17/2024 | Date of signature on the Form 4 filing. |
| 06/13/2025 | First vesting date for the newly acquired stock options. |
| 09/01/2025 | Expiration date of stock options that were exercised. |
| 06/13/2034 | Expiration date for the newly acquired stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.